TY - JOUR
T1 - Dissecting the metabolic signaling pathways by which microbial molecules drive the differentiation of regulatory B cells
AU - Luu, Maik
AU - Krause, Felix F.
AU - Monning, Heide
AU - Wempe, Anne
AU - Leister, Hanna
AU - Mainieri, Lisa
AU - Staudt, Sarah
AU - Ziegler-Martin, Kai
AU - Mangold, Kira
AU - Kappelhoff, Nora
AU - Shaul, Yoav D.
AU - Göttig, Stephan
AU - Plaza-Sirvent, Carlos
AU - Schulte, Leon N.
AU - Bekeredjian-Ding, Isabelle
AU - Schmitz, Ingo
AU - Steinhoff, Ulrich
AU - Visekruna, Alexander
N1 - Publisher Copyright:
© 2024 The Author(s)
PY - 2024
Y1 - 2024
N2 - The host-microbiome axis has been implicated in promoting anti-inflammatory immune responses. Yet, the underlying molecular mechanisms of commensal-mediated IL-10 production by regulatory B cells (Bregs) are not fully elucidated. Here, we demonstrate that bacterial CpG motifs trigger the signaling downstream of TLR9 promoting IκBNS-mediated expression of Blimp-1, a transcription regulator of IL-10. Surprisingly, this effect was counteracted by the NF-κB transcription factor c-Rel. A functional screen for intestinal bacterial species identified the commensal Clostridium sporogenes, secreting high amounts of short-chain fatty acids (SCFAs) and branched-chain fatty acids (BCFAs), as an amplifier of IL-10 production by promoting sustained mTOR signaling in B cells. Consequently, enhanced Breg functionality was achieved by combining CpG with the SCFA butyrate or the BCFA isovalerate thereby synergizing TLR- and mTOR-mediated pathways. Collectively, Bregs required two bacterial signals (butyrate and CpG) to elicit their full suppressive capacity and ameliorate T cell-mediated intestinal inflammation. Our study has dissected the molecular pathways induced by bacterial factors, which might contribute not only to better understanding of host-microbiome interactions, but also to exploration of new strategies for improvement of anti-inflammatory cellular therapy.
AB - The host-microbiome axis has been implicated in promoting anti-inflammatory immune responses. Yet, the underlying molecular mechanisms of commensal-mediated IL-10 production by regulatory B cells (Bregs) are not fully elucidated. Here, we demonstrate that bacterial CpG motifs trigger the signaling downstream of TLR9 promoting IκBNS-mediated expression of Blimp-1, a transcription regulator of IL-10. Surprisingly, this effect was counteracted by the NF-κB transcription factor c-Rel. A functional screen for intestinal bacterial species identified the commensal Clostridium sporogenes, secreting high amounts of short-chain fatty acids (SCFAs) and branched-chain fatty acids (BCFAs), as an amplifier of IL-10 production by promoting sustained mTOR signaling in B cells. Consequently, enhanced Breg functionality was achieved by combining CpG with the SCFA butyrate or the BCFA isovalerate thereby synergizing TLR- and mTOR-mediated pathways. Collectively, Bregs required two bacterial signals (butyrate and CpG) to elicit their full suppressive capacity and ameliorate T cell-mediated intestinal inflammation. Our study has dissected the molecular pathways induced by bacterial factors, which might contribute not only to better understanding of host-microbiome interactions, but also to exploration of new strategies for improvement of anti-inflammatory cellular therapy.
KW - Colitis
KW - Microbial metabolites
KW - Microbiota
KW - NF-kB
KW - Regulatory B cells
UR - http://www.scopus.com/inward/record.url?scp=85204078845&partnerID=8YFLogxK
U2 - 10.1016/j.mucimm.2024.09.003
DO - 10.1016/j.mucimm.2024.09.003
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 39265892
AN - SCOPUS:85204078845
SN - 1933-0219
JO - Mucosal Immunology
JF - Mucosal Immunology
ER -